Similar antitumour effects could be observed in CT26 or EMT6 tumour-bearing mice, which suggests that the TIOs-mediated antitumour effects are not limited to a particular tumour model (Supplementary Fig. 12). The gene discussed is DDX53; the disease is neoplasm.